Monday, October 18, 2010

Curing the Sick with Dual-Stick Shooting

Electronic Arts and Naked Sky Entertainment have announced the development of Microbot, a dual-stick shooter inside the body for download services next year.

In Microbot, players control a prototype nanobot which is no larger than a blood cell. The previous iterations of the robots, developed to eliminate diseases at a cellular level, have unfortunately bonded with the diseases, spreading and multiplying the infection to dangerous and potentially lethal levels. It is up to the newest prototype to destroy these machine-disease hybrids in order to save the lives of the infected.

The game's added twist to the usual dual-stick shooter game mechanic is the inclusion of internal fluid dynamics. As players venture from veins to bones to organs, bloodflow and pulsing movements from the body cause changes in the battlefield, making movement more strategic and unique. Furthermore, the developer is aware that no body is exactly the same; each time the game is played from the beginning, the layout of each area is changed to present new challenges with each playthrough. The game will also provide upgrades for the Microbot overtime, catering to each player's gameplay preferences.
“We wanted to take gamers to a place they have rarely visited before — the world inside the human body. The fluid dynamics of the world and the customization of the MicroBot come together to create a unique take on the arcade shooter genre."
- Jason Haber, Electronic Arts
The game will also feature drop-in/drop-out cooperative multiplayer modes.

Microbot is expected for release Winter 2011 for XBLA and PSN.

Naked Sky Entertainment is an independent development company based in Los Angeles comprised of MIT programmers as well as a number of award-winning artists and designers. The company's first venture into gaming came with RobotBlitz, the first XBLA title to use the Unreal 3 Engine back in 2006. It has since developed Star Trek D.A.C. which released in 2009.


See more Game Videos at


No comments:

Post a Comment